Nureca Ltd.

₹270 -2.4 | 0.9%

WEBSITE BSE:543264 NSE : NURECA 20 Jun, 10:50

Market Cap ₹270 Cr.

Stock P/E 319.2

P/B 1.4

Current Price ₹270

Book Value ₹ 194.3

Face Value 10

52W High ₹447

Dividend Yield 0%

52W Low ₹ 198

Edit Ratio

Nureca Ltd. Research see more...

Overview Inc. Year: 2016Industry: Medical Equipment/Supplies/Accessories

Nureca Limited, a B2C agency, engages in the domestic healthcare and well-being products commercial enterprise in India. It gives chronic disease merchandise, inclusive of nebulizers, blood pressure video display units, finger pulse oximeter, glucose meter, and thermometer; orthopaedic products, which includes massagers, ache monitors, posture correctors, and rehabilitation products; and humidifiers and steamers, non-public scales, yoga and exercising, health monitoring, and dental and personal care products. The organisation also provides mother and toddler care products comprising baby feeding, carry cots, infant skincare, and bottle heaters and steamers; nutritional supplements and weight control merchandise; and ECG, health tracker, and smart weighing scale merchandise. Nureca Ltd offers its merchandise underneath Dr Trust, Dr Physio, and Trumom brands. The enterprise sells its products via third party e-trade players, vendors, and retailers; and through its website, drtrust.In. Nureca Ltd was founded in 2016 and is primarily based in Chandigarh, India.

Nureca Ltd. Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Nureca Ltd. Quarterly Results

#(Fig in Cr.)	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Sales	28	21	21	31	22	17	20	31	26	32
Other Income	2	2	3	3	6	-1	6	3	1	2
Total Income	30	23	24	35	28	16	26	34	28	34
Total Expenditure	29	25	24	30	27	21	23	34	30	31
Operating Profit	1	-1	-0	5	2	-6	3	1	-3	3
Interest	0	0	0	0	0	0	0	0	0	1
Depreciation	1	1	1	1	1	1	1	1	1	1
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	-2	-1	4	1	-6	3	-0	-3	2
Provision for Tax	-0	-0	-0	1	1	-2	1	0	-0	-0
Profit After Tax	0	-2	-1	3	0	-4	2	-0	-3	2
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	0	-2	-1	3	0	-4	2	-0	-3	2
Adjusted Earnings Per Share	0.3	-1.5	-0.7	2.9	0.2	-4.1	1.7	-0.5	-2.8	2.5

Nureca Ltd. Profit & Loss

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Net Sales	20	62	99	213	256	111	92	110	109
Other Income	0	0	0	3	8	7	11	13	12
Total Income	20	62	99	216	263	118	102	122	122
Total Expenditure	16	53	90	152	200	126	102	117	118
Operating Profit	4	9	10	64	63	-8	0	5	4
Interest	0	0	1	2	1	0	0	1	1
Depreciation	0	0	0	0	1	2	2	2	4
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0
Profit Before Tax	4	9	9	62	61	-11	-3	1	2
Provision for Tax	1	3	2	16	16	-2	-1	0	1
Profit After Tax	3	6	6	46	45	-8	-2	1	1
Adjustments	0	0	0	0	0	0	0	0	0
Profit After Adjustments	3	6	6	46	45	-8	-2	1	1
Adjusted Earnings Per Share	444.6	889.4	913.6	46.4	45	-8.3	-1.8	0.8	0.9

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	20%	-25%	2%	0%
Operating Profit CAGR	0%	-57%	-13%	0%
PAT CAGR	0%	-72%	-30%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-2%	-34%	NA%	NA%
ROE Average	0%	-2%	14%	90%
ROCE Average	1%	-2%	19%	74%

Nureca Ltd. Balance Sheet

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Shareholder's Funds	2	8	15	163	203	195	193	194
Minority's Interest	0	0	0	0	0	0	0	0
Borrowings	0	0	9	1	0	0	0	1
Other Non-Current Liabilities	0	0	0	2	4	0	-2	-1
Total Current Liabilities	5	15	10	24	45	9	9	12
Total Liabilities	7	24	34	190	252	204	200	207
Fixed Assets	0	1	1	4	10	9	7	9
Other Non-Current Assets	0	0	0	0	3	9	1	8
Total Current Assets	7	23	33	186	239	187	193	190
Total Assets	7	24	34	190	252	204	200	207

Nureca Ltd. Cash Flow

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Opening Cash & Cash Equivalents	0	0	0	0	17	8	1	14
Cash Flow from Operating Activities	0	0	-8	35	1	10	-3	-19
Cash Flow from Investing Activities	-0	-0	-0	-110	-3	-16	18	8
Cash Flow from Financing Activities	-0	-0	8	92	-7	-2	-1	-0
Net Cash Inflow / Outflow	0	0	-0	17	-9	-8	14	-11
Closing Cash & Cash Equivalent	0	0	0	17	8	1	14	3

Nureca Ltd. Ratios

#	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Earnings Per Share (Rs)	444.57	889.43	913.57	46.37	44.96	-8.25	-1.79	0.85
CEPS(Rs)	445.43	897.57	967	46.8	46.44	-5.86	0.57	3.18
DPS(Rs)	0	0	0	2	3	0	0	0
Book NAV/Share(Rs)	104.29	993.57	1990.71	163.1	203.2	194.88	193.11	194.29
Core EBITDA Margin(%)	21.82	14.2	9.37	27.36	20.55	-12.87	-10.23	-6.4
EBIT Margin(%)	21.88	14.25	9.07	28.42	22.85	-8.83	-2.06	2.1
Pre Tax Margin(%)	21.56	13.87	8.32	27.71	22.57	-9.21	-2.54	1.1
PAT Margin (%)	15.52	9.77	6.18	20.62	16.64	-7.08	-1.79	0.69
Cash Profit Margin (%)	15.55	9.86	6.55	20.8	17.19	-5.03	0.57	2.61
ROA(%)	44.35	40.78	22.3	41.38	20.33	-3.62	-0.89	0.42
ROE(%)	426.3	162.03	61.23	52.39	24.55	-4.14	-0.92	0.44
ROCE(%)	255.06	179.97	56.7	67.61	33.57	-5.17	-1.06	1.31
Receivable days	30.69	30.18	38.39	10.65	2.11	11.25	10.79	7.39
Inventory Days	64.42	48.92	52.9	43.16	67.53	152.88	119.26	105.87
Payable days	172.97	68.29	44.04	26.74	18.53	23.46	30.6	31.48
PER(x)	0	0	0	12.98	30.3	0	0	248.64
Price/Book(x)	0	0	0	3.69	6.7	1.54	1.32	1.08
Dividend Yield(%)	0	0	0	0.33	0.22	0	0	0
EV/Net Sales(x)	-0	0.01	0.1	2.23	5	2.06	2.29	1.52
EV/Core EBITDA(x)	-0.01	0.04	1	7.41	20.22	-29.03	685.11	34.01
Net Sales Growth(%)	0	208.7	60.63	114.69	19.72	-56.44	-17.42	19.29
EBIT Growth(%)	0	107.07	3.27	581.55	-3.46	-116.67	80.03	224.43
PAT Growth(%)	0	100.06	2.71	625.16	-3.05	-118.35	78.25	147.16
EPS Growth(%)	0	100.06	2.71	-94.92	-3.05	-118.35	78.25	147.16
Debt/Equity(x)	0	0.06	0.7	0.01	0	0	0	0.01
Current Ratio(x)	1.32	1.5	3.45	7.78	5.28	21	20.77	15.32
Quick Ratio(x)	0.65	0.62	1.72	6.24	3.89	17.12	17.44	12.1
Interest Cover(x)	68.55	37.38	12.14	39.89	83.3	-22.87	-4.2	2.11
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0.01

Nureca Ltd. Shareholding Pattern

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	62.98	62.98	62.98	63.24	63.24	63.24	63.24	63.77	64.06	64.3
FII	0.1	0.1	0.1	0.1	0.07	0.07	0.07	0.69	0.36	1.07
DII	0	0	0	0	0	0	0	0	0	0
Public	36.91	36.91	36.91	36.66	36.69	36.69	36.69	35.53	35.58	34.62
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.64	0.64	0.64
FII	0	0	0	0	0	0	0	0.01	0	0.01
DII	0	0	0	0	0	0	0	0	0	0
Public	0.37	0.37	0.37	0.37	0.37	0.37	0.37	0.36	0.36	0.35
Others	0	0	0	0	0	0	0	0	0	0
Total	1	1	1	1	1	1	1	1	1	1

Pros

Company is almost debt free.

Cons

Company has a low return on equity of -2% over the last 3 years.
Debtor days have increased from 30.6 to 31.48days.
The company has delivered a poor profit growth of -30% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.